Results 41 to 50 of about 6,520,232 (298)

Circulating Tumor Cells and PET [PDF]

open access: yesJournal of Nuclear Medicine, 2011
Understanding the distinct molecular features of solid tumors provides the opportunity to develop more targeted and effective therapies. The evaluation and monitoring of these therapies require sophisticated laboratory and imaging technologies to detect potential benefit not necessarily translating into significant changes in tumor size.
Jian Q, Yu, Massimo, Cristofanilli
openaire   +2 more sources

Circulating cell-free DNA and circulating tumor cells, the “liquid biopsies” in ovarian cancer

open access: yesJournal of Ovarian Research, 2017
Limited understanding of ovarian cancer (OC) genome portrait has hindered the therapeutic advances. The serial monitoring of tumor genotypes is becoming increasingly attainable with circulating cell-free DNA (cf-DNA) and circulating tumor cells (CTCs ...
Xianliang Cheng   +3 more
doaj   +1 more source

Circulating Tumor Cell and Cell-free Circulating Tumor DNA in Lung Cancer [PDF]

open access: yesChonnam Medical Journal, 2016
Circulating tumor cells (CTCs) are tumor cells that are separated from the primary site or metastatic lesion and disseminate in blood circulation. CTCs are considered to be part of the long process of cancer metastasis. As a 'liquid biopsy', CTC molecular examination and investigation of single cancer cells create an important opportunity for providing
Nurwidya, Fariz   +6 more
openaire   +2 more sources

Supplementary Data from Tumor-Naïve Multimodal Profiling of Circulating Tumor DNA in Head and Neck Squamous Cell Carcinoma

open access: yes, 2021
Supplementary Data from Tumor-Naïve Multimodal Profiling of Circulating Tumor DNA in Head and Neck Squamous Cell ...
John N. Waldron (15032258)   +18 more
core   +1 more source

Clinical correlates of circulating cell-free DNA tumor fraction.

open access: yesPLoS ONE, 2021
BackgroundOncology applications of cell-free DNA analysis are often limited by the amount of circulating tumor DNA and the fraction of cell-free DNA derived from tumor cells in a blood sample.
Joerg Bredno   +4 more
doaj   +1 more source

Research progress on circulating tumor cells of hepatocellular carcinoma

open access: yesJournal of Interventional Medicine, 2021
Circulating tumor cells (CTCs) are the cells released from the primary tumor and found in the peripheral blood, which can colonize and develop at a distance through blood circulation. At present, the commonly used separation and detection methods of CTCs
Chenyu Wan, Bing Zhou
doaj   +1 more source

Application of circulating tumor cells scope technique on circulating tumor cell research [PDF]

open access: yesMolecular and Cellular Therapies, 2014
Circulating tumor cells (CTCs) are becoming promising biomarkers in several cancers, such as colon, prostate, and breast carcinomas. Independent research groups have reported a correlation between CTC numbers and patient prognosis. Even more, the development of personalized medicine gives physicians impetus to utilize the advancement of molecular ...
Yang, Dawei, Wang, Lijie, Tian, Xiaochen
openaire   +2 more sources

Non-invasive Technology Advances in Cancer—A Review of the Advances in the Liquid Biopsy for Endometrial and Ovarian Cancers

open access: yesFrontiers in Digital Health, 2020
Improving cancer survival rates globally requires improvements in disease detection and monitoring, with the aim of improving early diagnosis and prediction of disease relapse. Traditional means of detecting and monitoring cancers rely largely on imaging
Mark R. Openshaw, Terri P. McVeigh
doaj   +1 more source

Significance of Studying Circulating Tumor Cells

open access: yes, 2016
Circulating Tumor Cells (CTC) are tumor cells released into blood. They are considered the pivotal component of the metastatic cascade and are being extensively studied only in the last decade or so.
Richard J. Cote   +5 more
core   +1 more source

Circulating tumor cell number and disease outcome.

open access: yes, 2013
Circulating tumor cell number and disease outcome.
Philip Z. Brohawn (448864)   +12 more
core   +1 more source

Home - About - Disclaimer - Privacy